PCV serotypes | Hospitalization rates per 100,000 person-years | Relative difference in hospitalization rates | |||||
---|---|---|---|---|---|---|---|
2009 | 2011 | 2012 | 2009 to 2011 | 2009 to 2012 | |||
Rate (95Â % CI) | Rate (95Â % CI) | Rate (95Â % CI) | % (95Â % CI) | p | % (95Â % CI) | p | |
Any lytA-positive (SARI program) | |||||||
 PCV-7 | 125.1 (93.7–163.6) | 23.9 (11.9–42.8) | 45.2 (28.0–69.1) | −80.9 (−90.9 to −62.9) | <0.001 | −63.8 (−79.3 to −39.1) | <0.001 |
 PCV-13 | 37.8 (21.6–61.3) | 15.2 (6.1–31.3) | 34.4 (19.7–55.9) | −59.7 (−85.9 to +3.4) | 0.067 | +8.8 (−94.8 to +57.3) | 0.796 |
 NVT | 273.7 (226.2–328.3) | 47.8 (30.0–72.4) | 77.5 (54.3–107.3) | − 82.5 (−89.4 to −72.3) | <0.001 | −71.7 (−81.1 to −58.5) | <0.001 |
 All | 436.6 (375.9–504.2) | 86.9 (62.1–118.3) | 157.1 (123.2–197.6) | −80.1 (−86.2 to −71.8) | <0.001 | −64.0 (−72.9 to −52.6) | <0.001 |
Culture-positive (GERMS program) | |||||||
 PCV-7 | 77.9 (53.6–109.3) | 13.0 (4.8–28.4) | 6.5 (1.3–18.9) | −83.2 (−94.2 to – 59.5) | <0.001 | −91.7 (−98.4 to −73.6) | <0.001 |
 PCV-13 | 23.6 (11.3–43.4) | 17.4 (7.5–34.2) | 8.6 (2.3–22.1) | −26.3 (−74.7 to +107.3) | 0.529 | −63.5 (−91.6 to +26.5) | 0.084 |
 NVT | 28.3 (14.6–49.5) | 28.2 (15.0–48.3) | 28.0 (14.9–47.8) | −0.2 (−58.0 to +139.2) | 0.993 | +1.2 (−96.7 to +58.4) | 0.974 |
 All | 129.8 (97.8–168.9) | 58.6 (38.7–85.3) | 43.1 (26.3–66.5) | −54.8 (−72.6 to −27.1) | <0.001 | −66.8 (−81.2 to −43.8) | <0.001 |